Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Dovetail Genomics taps Dr. Ramesh Ramakrishnan to head R&D

Dovetail Genomics LLC
Posted on: 07 Aug 17
Dovetail Genomics taps Dr. Ramesh Ramakrishnan to head R&D

PR Newswire

SANTA CRUZ, Calif., Aug. 7, 2017

SANTA CRUZ, Calif., Aug. 7, 2017 /PRNewswire/ -- Dovetail Genomics™ LLC, the industry leader in the use of proximity ligation and advanced informatics for genomic solutions, has appointed Dr. Ramesh Ramakrishnan Senior Vice President of Research and Development. Prior to joining Dovetail, Dr. Ramakrishnan was Executive Vice President of Research and Development at Fluidigm Corp., where he managed the development of single cell genomic and proteomic tools, as well as bulk genomic analysis.

"We are thrilled to welcome Ramesh to the Dovetail team," said Todd Dickinson, CEO of Dovetail Genomics. "His deep experience in the development and commercialization of genomic products and solutions represents an important addition to the management team as we continue expanding our portfolio. Just as important, he will be responsible for identifying new opportunities to leverage our core expertise, driving the development of exciting new applications in genomics for our customers."

Dr. Ramakrishnan brings to Dovetail more than 25 years experience in biotech and clinical research, and in commercialization of genomic solutions. He holds a PhD in Zoology from Georgetown University and the University of Poona, India, which he earned through the Fulbright Scholarship Program. Prior to his tenure at Fluidigm, Dr. Ramakrishnan worked at Nanosphere and Motorola Life Sciences in assay and array development.

About Dovetail Genomics
Dovetail Genomics LLC is transforming genomics by making long-range information readily accessible to all. The company enables researchers and clinicians to solve complex problems involving de novo assembly, structural variation, microbiome analysis, cancer research, phasing analysis and more by providing them a more comprehensive view of the genome. Its proprietary in vitro proximity ligation approach and assembly algorithms simplify genomic discovery by integrating the highest quality long-range genomic information with next-gen sequencing output. Dovetail is based in Santa Cruz, California. For more information on Dovetail, its technology, and service offerings, visit Follow Dovetail on Twitter @DTGenomics.

View original content:

SOURCE Dovetail Genomics LLC

PR Newswire

Last updated on: 07/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.